Truvada was first approved for preventive use in the United States in 2012, and has been shown to significantly reduce the chance of infection.
By Donato Paolo Mancini, STAT
The HIV research community is increasingly optimistic about the “shock and kill” treatment approach, which appears to remove all traces of the virus from an individual’s body.
By Anne-christine d’Adesky, KQED Future of You
The next wave of regenerative medicine research is tackling enormous health care issues: AIDS, Alzheimer’s disease, diabetes and heart disease, among others.
By Jonathan Gertler, STAT
A new study pinpoints exactly when HIV arrived in the U.S., while also exonerating Gaëtan Dugas, a man once branded as "patient zero" and blamed for starting the outbreak.
By Nsikan Akpan
By PBS NewsHour
This week, Oxford University researchers released a study that may impact treatments for HIV. The study looked at young children in South Africa with HIV and found that 10 percent of them never developed symptoms of AIDS. Philip Goulder, a…
By Jon Cohen, Science
In South Africa, the Themba Lethu Clinic is celebrated as an example of what can be done to care for large numbers of HIV-infected people. This is at once a compliment to the clinic and a hint of the country’s…
Nearly one in five people infected with HIV globally lives in South Africa, and only half of those individuals are on treatment. But the nation has made major strides against the virus in recent years and now is aggressively moving…
By PBS NewsHour
A massive HIV test-and-treat study is underway in Kenya and Uganda. Migratory men in the fishing industry there have been hit especially hard, and researchers are trying creative ways to encourage them to get tested. William Brangham reports from Mfangano…
Rwanda emerged from its genocide in 1994 to build one of the most successful AIDS responses in Africa and is now working mightily to halt mother-to-child HIV transmissions. They’re doing it with a creative mix of science, technology and “aggressive…
Support Provided By: Learn more